McEwen Inc. Insider Florek Files Form 4 on March 23, 2026

TL;DR

**Insider Florek filed a Form 4 for McEwen Inc., signaling potential ownership changes.**

AI Summary

This Form 4 filing indicates that John Casimir Florek, an insider at McEwen Inc., filed a statement of changes in beneficial ownership of securities on March 23, 2026, for a period ending March 19, 2026. While the filing itself doesn't detail specific transactions, it signals that an insider's holdings may have changed. This matters to investors because insider activity, especially buying or selling, can sometimes signal management's confidence (or lack thereof) in the company's future prospects, potentially influencing stock price.

Why It Matters

This filing alerts investors to potential changes in insider ownership at McEwen Inc., which can be a key indicator of future company performance or management sentiment.

Risk Assessment

Risk Level: low — This filing is purely administrative and does not inherently indicate a high-risk event without transaction details.

Analyst Insight

A smart investor would monitor subsequent filings from Florek John Casimir or McEwen Inc. for specific transaction details (e.g., buys or sells) to understand the nature and magnitude of any change in beneficial ownership, as this filing only indicates a change occurred or is being reported.

Key Players & Entities

• Florek John Casimir (person) — Reporting Person (insider)
• McEwen Inc. (company) — Issuer of securities
• 0002074273 (person) — CIK for Florek John Casimir
• 0000314203 (company) — CIK for McEwen Inc.

FAQ

Filing Documents

• tm269595-4_4seq1.html (4)
• tm269595-4_4seq1.xml (4) — 4KB
• 0001104659-26-033382.txt ( ) — 6KB

From the Filing

SEC FORM 4 SEC Form 4 FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10. 1. Name and Address of Reporting Person * Florek John Casimir (Last) (First) (Middle) C/O MCEWEN INC. 150 KING STREET WEST, SUITE 2800 (Street) TORONTO M5H 1J9 (City) (State) (Zip) ONTARIO, CANADA (Country) 2. Issuer Name and Ticker or Trading Symbol McEwen Inc. [ MUX ] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X Director 10% Owner Officer (give title below) Other (specify below) 2a. Foreign Trading Symbol 3. Date of Earliest Transaction (Month/Day/Year) 03/19/2026 6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person 4. If Amendment, Date of Original Filed (Month/Day/Year) Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Deferred Stock Units (1) 03/19/2026 A 479 (2) (2) Common Stock 479 $ 0 1,790 D Explanation of Responses: 1. Each deferred stock unit represents a right to receive one share of the Issuer's common stock. 2. The deferred stock units are fully vested and will be delivered to the reporting person on the date of the reporting person's termination of continuous service from the Issuer's Board of Directors (the "Board"), subject to the reporting person's right to elect to defer delivery of the deferred stock units beyond the date of the reporting person's termination of continuous service from the Board. /s/ John Casimir Florek 03/23/2026 ** Signature of Reporting Person Date Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. * If the form is filed by more than one reporting person, see Instruction 4 (b)(v). ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. * Form 4: SEC 1474 (03-26)

View Full Filing

View this 4 filing on SEC EDGAR